2019年1月4日の国民人民会議で、第4回特許法改正草案が発表されました。この草案は、今度の特許法改革の焦点となる点を示したもので、コメントが寄せられるよう一般に公開されました。
2019年1月4日の国民人民会議で、第4回特許法改正草案が発表されました。この草案は、今度の特許法改革の焦点となる点を示したもので、コメントが寄せられるよう一般に公開されました。
In the most recent judgement in the Australian Lyrica® litigation Nicholas J has delivered an interesting decision regarding whether applying for Pharmaceutical Benefits Scheme (PBS) listing constitutes infringement of...
In the most recent judgement in the Australian Lyrica® litigation Nicholas J has delivered an interesting decision regarding whether...
The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein a known substance is to be used in a novel...
The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein...
The current provisions in the Australian Patents Act providing for extensions of term for pharmaceutical patents were introduced in 1998. They provide for an effective 15 year patent life...
The current provisions in the Australian Patents Act providing for extensions of term for pharmaceutical patents were introduced in...